Muhammad Sajawal Ali

Muhammad Sajawal Ali

Auto-generated profile, based on publicly available information

Muhammad Sajawal Ali

Department of Cardiothoracic Surgery Weill Cornell Medicine New York New York USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2017 in Respirology
Verified
Journal Article
Closed access
PDF file
MAMuhammad S. Ali
Muhammad S. Ali
WTWilliam Trick
William Trick
BMBenjamin I. Mba
Benjamin I. Mba
DMDivyanshu Mohananey
Divyanshu Mohananey
JSJaskaran Sethi
Jaskaran Sethi
AMAli I. Musani
Ali I. Musani

1 December 2023 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
MAMuhammad Sajawal Ali
Muhammad Sajawal Ali
UGUzair Khan Ghori
Uzair Khan Ghori
MWMax Theodore Wayne
Max Theodore Wayne
ESEugene Shostak
Eugene Shostak
JCJose De Cardenas
Jose De Cardenas
Rationale: Conventional electromagnetic navigation bronchoscopy and other guided bronchoscopic modalities have a very desirable safety profile, but their diagnostic yield is only 60–70% for pulmonary lesions. Recently, robotic-assisted bronchoscopy (RAB) platforms have been introduced to improve the diagnostic performance of bronchoscopic modalities. Objectives: To determine the diagnostic performance and safety profile of RAB (using shape-sensing and electromagnetic navigation–based platforms) by performing a systematic review and meta-analysis. Methods: The PubMed, Embase, and Google Scholar databases were searched to find studies that reported on the diagnostic performance and/or the safety profile of one of the RAB systems. The quality of included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 tool. Meta-analysis was performed using MedCalc version 20.118. Pooled diagnostic yield was calculated using a Freeman-Tukey transformation. We planned to use a random-effects model if the I 2 index was >40%. Results: Twenty-five studies were included: 20 including diagnostic and safety analyses and 5 including only safety analyses. The pooled diagnostic yield of RAB (20 studies, 1,779 lesions) was 84.3% (95% confidence interval, 81.1–87.2%). The I 2 index was 65.6%. On the basis of our subgroup analyses, the heterogeneity was likely driven by differences in study designs (prospective vs. retrospective) and procedural protocols (such as different RAB systems). Lesion size > 2 cm, the presence of a computed tomography bronchus sign, and concentric radial endobronchial ultrasound view were associated with a statistically significant increase in the odds of diagnosis with RAB. The overall rates of pneumothorax, need for tube thoracostomy, and significant hemorrhage were 2.3%, 1.2%, and 0.5%, respectively. Conclusions: RAB systems have significantly increased the diagnostic yield of navigational bronchoscopy compared with conventional systems such as electromagnetic navigation bronchoscopy, but well-designed prospective studies are needed to better understand the impact of various factors, such as the use of three-dimensional imaging modalities, cryobiopsy, and specific ventilatory protocols, on the diagnostic yield of RAB.

1 August 2018 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
MAMuhammad S. Ali
Muhammad S. Ali
JSJaskaran Sethi
Jaskaran Sethi
ATAmit Taneja
Amit Taneja
AMAli Musani
Ali Musani
FMFabien Maldonado
Fabien Maldonado
Rationale: Indeterminate peripheral pulmonary lesions (PPLs) often require tissue diagnosis. If nonsurgical biopsy techniques are considered, deciding between bronchoscopic transbronchial versus computed tomography–guided transthoracic biopsy can be difficult. The former has a low diagnostic yield with a low complication risk, whereas the latter has a better diagnostic yield but a higher complication rate. Investigators have looked at various lesion characteristics that can predict the diagnostic yield of guided bronchoscopic biopsies. Although consensus exists that larger size and proximity to the hilum increase the diagnostic yield, there is ongoing debate about the association between computed tomography bronchus sign (air-filled bronchus in close proximity of the lesion as seen on computed tomography imaging) and the diagnostic yield of guided bronchoscopic modalities. Objectives: To perform a meta-analysis and systematic review, determining the association between computed tomography bronchus sign and the diagnostic yield of guided bronchoscopy for PPLs. Methods: MEDLINE, Embase, Scopus, and Google Scholar were searched in January 2018 for guided bronchoscopy studies that had assessed the impact of computed tomography bronchus sign on the diagnostic yield. The quality of included studies was assessed using Quality Assessment of Diagnostic Accuracy Studies-2 tool. Meta-analysis was performed using MedCalc (version 18). Odds ratios were used to compare yield of lesions with and without bronchus sign. Random effects model was used when significant heterogeneity was observed (I 2 > 40%). Results: For 2,199 lesions with computed tomography bronchus sign, the overall weighted diagnostic yield was 74.1% (95% confidence interval, 68.3–79.5%). For 971 lesions without computed tomography bronchus sign, the overall weighted diagnostic yield was 49.6% (95% confidence interval, 39.6–59.5%). The odds ratio for successfully diagnosing a lesion with computed tomography bronchus sign was 3.4 (95% confidence interval, 2.4–5.0). Possible sources of heterogeneity in the meta-analysis included differences in study designs, guidance modalities, and cancer prevalence. The odds ratio for successfully diagnosing a lesion with computed tomography bronchus sign was relatively lower for prospective studies. Conclusions: PPLs with computed tomography bronchus sign are more likely to be diagnosed with guided bronchoscopy than the lesions without computed tomography bronchus sign. Clinicians should consider this, along with the lesion size and distance from the hilum, when contemplating guided bronchoscopy for PPLs.

30 January 2011 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
MAMuhammad Ali
Muhammad Ali
AAAshwin N. Ananthakrishnan
Ashwin N. Ananthakrishnan
EMEmily L. McGinley
Emily L. McGinley
KSKia Saeian
Kia Saeian

14 April 2012 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
MAMuhammad Ali
Muhammad Ali
AAAshwin N. Ananthakrishnan
Ashwin N. Ananthakrishnan
SAShahryar Ahmad
Shahryar Ahmad
NKNilay Kumar
Nilay Kumar
GKGagan Kumar
Gagan Kumar
KSKia Saeian
Kia Saeian
The incidence of Clostridium difficile infection (CDI) is increasing among hospitalized patients. Liver transplantation (LT) patients are at higher risk for acquiring CDI. Small, single-center studies (but no nationwide analyses) have assessed this association. We used the Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project (2004-2008) for this retrospective, cross-sectional study. Patients with any discharge diagnosis of LT composed the study population, and they were identified with International Classification of Diseases, Ninth Revision, Clinical Modification codes. Those with a discharge diagnosis of CDI were considered cases. Our primary outcomes were the prevalence of CDI and the effects of CDI on inpatient mortality. Our secondary outcomes included the length of stay and hospitalization charges. A regression analysis was used to derive odds ratios (ORs) adjusted for potential confounders. There were 193,174 discharges with a diagnosis of LT from 2004 to 2008. The prevalence of CDI was 2.7% in the LT population and 0.9% in the non-LT population (P < 0.001). Most of the LT patients were 50 to 64 years old. LT patients had higher odds of developing CDI [OR = 2.88, 95% confidence interval (CI) = 2.68-3.10]. Increasing age and increasing comorbidity (including inflammatory bowel disease and nasogastric tube placement) were also independent CDI risk factors. CDI was associated with a higher mortality rate: 5.5% for LT patients with CDI versus 3.2% for LT-only patients (adjusted OR = 1.70, 95% CI = 1.29-2.25). In conclusion, the prevalence of CDI is higher for LT patients versus non-LT patients (2.7% versus 0.9%). CDI is an independent risk factor for mortality in the LT population. Liver Transpl, 2012. © 2012 AASLD.

1 January 2020 in Chest
Verified
Journal Article
Closed access
MSMajid Shafiq
Majid Shafiq
JSJaskaran Sethi
Jaskaran Sethi
MAMuhammad S. Ali
Muhammad S. Ali
UGUzair K. Ghori
Uzair K. Ghori
TSTajalli Saghaie
Tajalli Saghaie
EFErik Folch
Erik Folch